Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Creager

Showing results (91-100 of 292) with videos related to

Pageof 30
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|July 26, 2003
Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitusJoshua A Beckman, Allison B Goldfine, Mary Beth Gordon, et al.
Vascular Medicine (London, England)|July 3, 2004
Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacyWilliam R Hiatt, Alan T Hirsch, John P Cooke, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|November 13, 2020
Automated Detection of Exercise Sessions in Patients With Peripheral Artery Disease: EVIDENCE FOR AN EXERCISE DOSE RESPONSE TO TRAININGRyan J Mays, Craig W Wesselman, Robin White, et al.
Journal of the American College of Cardiology|December 17, 2025
Management of Peripheral Artery Disease in Adults With Diabetes: 2025 ACC Scientific Statement: A Report of the American College of CardiologySandeep R Das, Marc P Bonaca, Mark A Creager, et al.
Circulation Research|November 11, 2006
Rho kinase inhibition improves endothelial function in human subjects with coronary artery diseaseAnju Nohria, Matthew E Grunert, Yoshiyuki Rikitake, et al.
Atherosclerosis|January 27, 2009
Statins inhibit Rho kinase activity in patients with atherosclerosisAnju Nohria, Adnan Prsic, Ping-Yen Liu, et al.
Journal of Vascular Surgery|May 29, 2012
Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass graftsJade S Hiramoto, Christopher D Owens, Ji Min Kim, et al.
Annals of Internal Medicine|June 8, 2011
Smoking, smoking cessation, [corrected] and risk for symptomatic peripheral artery disease in women: a cohort studyDavid Conen, Brendan M Everett, Tobias Kurth, et al.
Magnetic Resonance in Medicine|May 19, 2009
In vivo differentiation of two vessel wall layers in lower extremity peripheral vein bypass grafts: application of high-resolution inner-volume black blood 3D FSEDimitris Mitsouras, Christopher D Owens, Michael S Conte, et al.
The American Journal of Cardiology|February 7, 2009
Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic eventRon Rawlings, Anju Nohria, Ping-Yen Liu, et al.
Pageof 30

Showing results (91-100 of 292) with videos related to

Sort By:
Pageof 30
American Journal of Physiology. Heart and Circulatory Physiology|July 26, 2003
Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitusJoshua A Beckman, Allison B Goldfine, Mary Beth Gordon, et al.
Vascular Medicine (London, England)|July 3, 2004
Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacyWilliam R Hiatt, Alan T Hirsch, John P Cooke, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|November 13, 2020
Automated Detection of Exercise Sessions in Patients With Peripheral Artery Disease: EVIDENCE FOR AN EXERCISE DOSE RESPONSE TO TRAININGRyan J Mays, Craig W Wesselman, Robin White, et al.
Journal of the American College of Cardiology|December 17, 2025
Management of Peripheral Artery Disease in Adults With Diabetes: 2025 ACC Scientific Statement: A Report of the American College of CardiologySandeep R Das, Marc P Bonaca, Mark A Creager, et al.
Circulation Research|November 11, 2006
Rho kinase inhibition improves endothelial function in human subjects with coronary artery diseaseAnju Nohria, Matthew E Grunert, Yoshiyuki Rikitake, et al.
Atherosclerosis|January 27, 2009
Statins inhibit Rho kinase activity in patients with atherosclerosisAnju Nohria, Adnan Prsic, Ping-Yen Liu, et al.
Journal of Vascular Surgery|May 29, 2012
Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass graftsJade S Hiramoto, Christopher D Owens, Ji Min Kim, et al.
Annals of Internal Medicine|June 8, 2011
Smoking, smoking cessation, [corrected] and risk for symptomatic peripheral artery disease in women: a cohort studyDavid Conen, Brendan M Everett, Tobias Kurth, et al.
Magnetic Resonance in Medicine|May 19, 2009
In vivo differentiation of two vessel wall layers in lower extremity peripheral vein bypass grafts: application of high-resolution inner-volume black blood 3D FSEDimitris Mitsouras, Christopher D Owens, Michael S Conte, et al.
The American Journal of Cardiology|February 7, 2009
Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic eventRon Rawlings, Anju Nohria, Ping-Yen Liu, et al.
Pageof 30